IL160998A0 - Human tissue factor antibodies - Google Patents

Human tissue factor antibodies

Info

Publication number: IL160998A0
Authority: IL; Israel
Prior art keywords: human tissue; tissue factor; factor antibodies; antibodies; human
Prior art date: 2001-10-02

Application number

IL16099802A

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-02

Filing date

2002-09-30

Publication date

2004-08-31

2002-09-30 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2004-08-31 Publication of IL160998A0 publication Critical patent/IL160998A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biophysics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL16099802A 2001-10-02 2002-09-30 Human tissue factor antibodies IL160998A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200101437		2001-10-02
PCT/DK2002/000644 WO2003029295A1 (en)	2001-10-02	2002-09-30	Human tissue factor antibodies

Publications (1)

Publication Number	Publication Date
IL160998A0 true IL160998A0 (en)	2004-08-31

Family

ID=8160743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16099802A IL160998A0 (en)	2001-10-02	2002-09-30	Human tissue factor antibodies

Country Status (15)

Country	Link
EP (1)	EP1434802A1 (en)
JP (1)	JP2005512970A (en)
KR (1)	KR20040045478A (en)
CN (1)	CN1575302A (en)
BR (1)	BR0213046A (en)
CA (1)	CA2460917A1 (en)
CZ (1)	CZ2004454A3 (en)
HU (1)	HUP0401658A2 (en)
IL (1)	IL160998A0 (en)
MX (1)	MXPA04003051A (en)
NO (1)	NO20041802L (en)
PL (1)	PL368989A1 (en)
RU (1)	RU2004113373A (en)
WO (1)	WO2003029295A1 (en)
ZA (1)	ZA200402303B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7749498B2 (en)	1997-03-10	2010-07-06	Genentech, Inc.	Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en)	1997-03-10	1999-11-16	Sunol Molecular Corporation	Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en)	2001-11-21	2003-06-12	Sunol Molecular Corporation	Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en)	1997-03-10	2006-10-19	Jin-An Jiao	Use of anti-tissue factor antibodies for treating thromboses
EP1374896A4 (en) *	2001-03-26	2005-04-06	Koji Suzuki	Blood rheology improving agents
AU2003277832A1 (en) *	2002-10-31	2004-05-25	Novo Nordisk A/S	Humanized tissue factor antibodies
EP1587549A2 (en) *	2003-01-22	2005-10-26	Novo Nordisk A/S	Radiolabelled tissue factor binding agent and the use thereof
US7605235B2 (en)	2003-05-30	2009-10-20	Centocor, Inc.	Anti-tissue factor antibodies and compositions
US9708410B2 (en)	2003-05-30	2017-07-18	Janssen Biotech, Inc.	Anti-tissue factor antibodies and compositions
EP1633309A4 (en) *	2003-05-30	2007-06-13	Centocor Inc	Method of inhibiting tumor growth with anti-tissue factor antibodies
MXPA05013789A (en) *	2003-06-19	2006-06-27	Tanox Inc	Compositions and methods for treating coagulation related disorders.
JP2007504167A (en) *	2003-08-29	2007-03-01	セントカー・インコーポレーテツド	Methods for improving graft survival using anti-tissue factor antibodies
JP2007523099A (en) *	2004-02-20	2007-08-16	ノボ　ノルディスク　アクティーゼルスカブ	Combination therapy
CN101512008B (en)	2006-09-08	2015-04-01	艾伯维巴哈马有限公司	Interleukin-13 binding proteins
CN101423552B (en) *	2008-02-29	2012-05-16	复旦大学	Human-derived anti-human tissue factor Fab and preparation method thereof
UA109633C2 (en) *	2008-12-09	2015-09-25		HUMAN ANTIBODY AGAINST TISSUE FACTOR
AU2016277670B2 (en) *	2008-12-09	2019-02-07	Genmab A/S	Human antibodies against tissue factor
AU2013203150B2 (en) *	2008-12-09	2016-09-22	Genmab A/S	Human antibodies against tissue factor
WO2010131235A1 (en) *	2009-05-15	2010-11-18	University Of The Free State	Inhibitory antibody fragments to human tissue factor
CA2802782C (en)	2010-06-15	2018-03-13	Genmab A/S	Human antibody drug conjugates against tissue factor
US8722044B2 (en)	2011-03-15	2014-05-13	Janssen Biotech, Inc.	Human tissue factor antibody and uses thereof
WO2017028823A1 (en) *	2015-08-20	2017-02-23	复旦大学	Antibody targeted against tissue factor, preparation method therefor, and use thereof
EP3502141A4 (en) *	2016-08-22	2020-04-08	Fudan University	TISSUE FACTOR TARGET ANTIBODIES, PREPARATION METHOD AND USE THEREOF
CN106938051B (en)	2016-08-22	2019-10-11	复旦大学	Antibody-drug conjugates targeting tissue factor
TWI841554B (en)	2018-03-21	2024-05-11	丹麥商珍美寶股份有限公司	Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate
SG11202010993VA (en)	2018-05-07	2020-12-30	Genmab As	Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate
TWI844571B (en)	2018-10-30	2024-06-11	丹麥商珍美寶股份有限公司	Methods of treating cancer with a combination of an anti-vegf antibody and an anti-tissue factor antibody-drug conjugate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223427A (en) *	1987-03-31	1993-06-29	The Scripps Research Institute	Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
US6001978A (en) *	1987-03-31	1999-12-14	The Scripps Research Institute	Human tissue factor related DNA segments polypeptides and antibodies
JP2779193B2 (en) *	1989-02-02	1998-07-23	帝人株式会社	Anti-human tissue factor monoclonal antibody
JP4423680B2 (en) *	1995-06-07	2010-03-03	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	CDR-grafted anti-tissue factor antibody and use thereof
TR200101541T2 (en) *	1998-04-03	2002-06-21	Chugai Seiyaku Kabushiki Kaisha	Humanized antibody against human tissue factor (TF).
JP3859512B2 (en) *	1999-10-01	2006-12-20	中外製薬株式会社	Prevention and treatment of blood coagulation-related diseases
AU5081401A (en) *	2000-03-16	2001-10-03	Genentech Inc	Anti-tissue factor antibodies with enhanced anticoagulant potency

2002
- 2002-09-30 HU HU0401658A patent/HUP0401658A2/en unknown
- 2002-09-30 PL PL02368989A patent/PL368989A1/en not_active Application Discontinuation
- 2002-09-30 CZ CZ2004454A patent/CZ2004454A3/en unknown
- 2002-09-30 CA CA002460917A patent/CA2460917A1/en not_active Abandoned
- 2002-09-30 BR BR0213046-7A patent/BR0213046A/en not_active IP Right Cessation
- 2002-09-30 EP EP02800043A patent/EP1434802A1/en not_active Withdrawn
- 2002-09-30 WO PCT/DK2002/000644 patent/WO2003029295A1/en not_active Ceased
- 2002-09-30 JP JP2003532540A patent/JP2005512970A/en not_active Withdrawn
- 2002-09-30 MX MXPA04003051A patent/MXPA04003051A/en unknown
- 2002-09-30 CN CNA028208463A patent/CN1575302A/en active Pending
- 2002-09-30 RU RU2004113373/13A patent/RU2004113373A/en not_active Application Discontinuation
- 2002-09-30 IL IL16099802A patent/IL160998A0/en unknown
- 2002-09-30 KR KR10-2004-7004942A patent/KR20040045478A/en not_active Withdrawn
2004
- 2004-03-24 ZA ZA200402303A patent/ZA200402303B/en unknown
- 2004-04-30 NO NO20041802A patent/NO20041802L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2460917A1 (en)	2003-04-10
WO2003029295A1 (en)	2003-04-10
CN1575302A (en)	2005-02-02
NO20041802L (en)	2004-04-30
RU2004113373A (en)	2005-03-27
HUP0401658A2 (en)	2004-11-29
PL368989A1 (en)	2005-04-04
JP2005512970A (en)	2005-05-12
EP1434802A1 (en)	2004-07-07
MXPA04003051A (en)	2004-07-05
KR20040045478A (en)	2004-06-01
ZA200402303B (en)	2004-11-25
CZ2004454A3 (en)	2004-09-15
BR0213046A (en)	2005-06-28

Publication	Publication Date	Title
IL160998A0 (en)	2004-08-31	Human tissue factor antibodies
HU230006B1 (en)	2015-04-28	Antagonistic anti-htnfsf13b human antibodies
EP1390390A4 (en)	2009-07-08	Human secreted proteins
GB0106588D0 (en)	2001-05-09	Tissue distracter
GB0218205D0 (en)	2002-09-11	Human ZZAP1 protein
EP1385381A4 (en)	2005-02-09	Human secreted proteins
AU2003226899A8 (en)	2003-09-29	Human diabetes-mediating proteins
HUP0402334A3 (en)	2007-03-28	Modified human growth hormone
AU2003287016A8 (en)	2004-04-23	Human sarcoma-associated antigens
GB0410094D0 (en)	2004-06-09	Human RAS interacting protein
GB0410147D0 (en)	2004-06-09	Human angiomotin-like protein 1
GB0226332D0 (en)	2002-12-18	Skin preparation
AU2002257630A1 (en)	2002-09-24	Human mrp5-like protein
AU148103S (en)	2002-06-06	Tissue
GB0201819D0 (en)	2002-03-13	Human posh-like protein 1
GB0201681D0 (en)	2002-03-13	Human ralgds-like protein 3
GB0116885D0 (en)	2001-09-05	Tissue implant
GB0116886D0 (en)	2001-09-05	Tissue implant
GB0116888D0 (en)	2001-09-05	Tissue implant
TWI315313B (en)	2009-10-01	Human coagulation factor vii variants
GB0119193D0 (en)	2001-09-26	Medical use
GB0110881D0 (en)	2001-06-27	Medical use
AU9481201A (en)	2002-04-08	Human nedd-1
GB0403407D0 (en)	2004-03-24	Four human zinc-finger-containing proteins: mdz3,mdz4,mdz7 and mdz12
AU145797S (en)	2001-11-02	Medical dressing